Re-definition of claudin-low as a breast cancer phenotype

Por Fougner, Christian, Bergholtz, Helga, Norum, Jens Henrik, Sørlie, Therese
Publicado no Nat Commun (2020)

Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers

Por Fougner, Christian, Bergholtz, Helga, Kuiper, Raoul, Norum, Jens Henrik, Sørlie, Therese
Publicado no Breast Cancer Res (2019)

Comparable cancer‐relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer

Por Bergholtz, Helga, Kumar, Surendra, Wärnberg, Fredrik, Lüders, Torben, Kristensen, Vessela, Sørlie, Therese
Publicado no Cancer Rep (Hoboken) (2020)

The tankyrase inhibitor G007-LK inhibits small intestine LGR5(+) stem cell proliferation without altering tissue morphology

Por Norum, Jens Henrik, Skarpen, Ellen, Brech, Andreas, Kuiper, Raoul, Waaler, Jo, Krauss, Stefan, Sørlie, Therese
Publicado no Biol Res (2018)

NMD Microarray Analysis for Rapid Genome-Wide Screen of Mutated Genes in Cancer

Por Wolf, Maija, Edgren, Henrik, Muggerud, Aslaug, Kilpinen, Sami, Huusko, Pia, Sørlie, Therese, Mousses, Spyro, Kallioniemi, Olli
Publicado no Cell Oncol (2005)

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms

Por Naume Bjørn, Xiao Chunlin, Johnsen Hilde, Wang Yulei, Sørlie Therese, Samaha Raymond R, Børresen-Dale Anne-Lise
Publicado em 2006-05-01

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms

Por Sørlie, Therese, Wang, Yulei, Xiao, Chunlin, Johnsen, Hilde, Naume, Bjørn, Samaha, Raymond R, Børresen-Dale, Anne-Lise
Publicado em 2006

Data integration from two microarray platforms identifies bi-allelic genetic inactivation of RIC8A in a breast cancer cell line

Por Muggerud, Aslaug Aamodt, Edgren, Henrik, Wolf, Maija, Kleivi, Kristine, Dejeux, Emelyne, Tost, Jörg, Sørlie, Therese, Kallioniemi, Olli
Publicado em 2009

The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study

Por Borgquist, Signe, Zhou, Wenjing, Jirström, Karin, Amini, Rose-Marie, Sollie, Thomas, Sørlie, Therese, Blomqvist, Carl, Butt, Salma, Wärnberg, Fredrik
Publicado no BMC Cancer (2015)

Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions

Por Bergholtz, Helga, Lien, Tonje G., Swanson, David M., Frigessi, Arnoldo, Daidone, Maria Grazia, Tost, Jörg, Wärnberg, Fredrik, Sørlie, Therese
Publicado no NPJ Breast Cancer (2020)

Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study

Por Zhou, Wenjing, Jirström, Karin, Amini, Rose-Marie, Fjällskog, Marie-Louise, Sollie, Thomas, Lindman, Henrik, Sørlie, Therese, Blomqvist, Carl, Wärnberg, Fredrik
Publicado no BMC Cancer (2013)

Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution

Por Zhou, Wenjing, Muggerud, Aslaug A., Vu, Phuong, Due, Eldri U., Sørlie, Therese, Børresen-Dale, Anne-Lise, Wärnberg, Fredrik, Langerød, Anita
Publicado no Mol Oncol (2009)

Evaluation of MetriGenix custom 4D™ arrays applied for detection of breast cancer subtypes

Por Muggerud, Aslaug Aamodt, Johnsen, Hilde, Barnes, Debra A, Steel, Adam, Lønning, Per Eystein, Naume, Bjørn, Sørlie, Therese, Børresen-Dale, Anne-Lise
Publicado em 2006

In Silico Ascription of Gene Expression Differences to Tumor and Stromal Cells in a Model to Study Impact on Breast Cancer Outcome

Por Myhre, Simen, Mohammed, Hayat, Tramm, Trine, Alsner, Jan, Finak, Greg, Park, Morag, Overgaard, Jens, Børresen-Dale, Anne-Lise, Frigessi, Arnoldo, Sørlie, Therese
Publicado em 2010

Merging transcriptomics and metabolomics - advances in breast cancer profiling

Por Borgan, Eldrid, Sitter, Beathe, Lingjærde, Ole Christian, Johnsen, Hilde, Lundgren, Steinar, Bathen, Tone F, Sørlie, Therese, Børresen-Dale, Anne-Lise, Gribbestad, Ingrid S
Publicado em 2010

Differential In Vivo Tumorigenicity of Distinct Subpopulations from a Luminal-Like Breast Cancer Xenograft

Por Skrbo, Nirma, Hjortland, Geir-Olav, Kristian, Alexandr, Holm, Ruth, Nord, Silje, Prasmickaite, Lina, Engebraaten, Olav, Mælandsmo, Gunhild M., Sørlie, Therese, Andersen, Kristin
Publicado no PLoS One (2014)

Combining Gene Signatures Improves Prediction of Breast Cancer Survival

Por Zhao, Xi, Rødland, Einar Andreas, Sørlie, Therese, Naume, Bjørn, Langerød, Anita, Frigessi, Arnoldo, Kristensen, Vessela N., Børresen-Dale, Anne-Lise, Lingjærde, Ole Christian
Publicado em 2011

Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue

Por Borgan, Eldrid, Navon, Roy, Vollan, Hans Kristian Moen, Schlichting, Ellen, Sauer, Torill, Yakhini, Zohar, Lingjærde, Ole Christian, Sørlie, Therese, Børresen-Dale, Anne-Lise
Publicado no Mol Oncol (2011)

Subtype‐specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts

Por Borgan, Eldrid, Lindholm, Evita M., Moestue, Siver, Mælandsmo, Gunhild M., Lingjærde, Ole Christian, Gribbestad, Ingrid S., Børresen-Dale, Anne-Lise, Engebraaten, Olav, Sørlie, Therese
Publicado no Mol Oncol (2012)

Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status

Por Zhao, Xi, Rødland, Einar Andreas, Sørlie, Therese, Vollan, Hans Kristian Moen, Russnes, Hege G, Kristensen, Vessela N, Lingjærde, Ole Christian, Børresen-Dale, Anne-Lise
Publicado em 2014